Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

Hypertension
H MatsuokaT Imaizumi

Abstract

Nitric oxide inhibits proliferation and migration of vascular smooth muscle cells and contractility of cardiomyocytes in vitro. In spontaneously hypertensive rats (SHR), evidence suggests intrinsic abnormalities of the L-arginine-nitric oxide axis, such as low cGMP-dependent protein kinase in the heart and abnormal L-arginine metabolism. To investigate the in vivo effect of L-arginine on cardiac hypertrophy, 30 SHR and 30 Wistar-Kyoto rats (WKY) were randomly grouped to receive L-arginine (7.5 g/L in drinking water) or vehicle for 12 weeks. L-Arginine treatment did not affect body weight or arterial pressure in either strain. In vehicle-treated animals, the heart/body weight ratio was significantly higher in SHR than in WKY (P < .01). L-Arginine treatment decreased the heart/body weight ratio in SHR (P < .05) but did not affect it in WKY. Expression of skeletal alpha-actin mRNA, known to be expressed in the hypertrophied myocardium, was attenuated in L-arginine-treated SHR compared with vehicle-treated SHR. Cardiac cGMP content and nitrate/nitrite content were less in SHR than WKY. L-Arginine treatment increased these levels only in SHR, suggesting enhanced nitric oxide production. Thus, chronic L-arginine administration attenu...Continue Reading

References

Nov 1, 1991·The Journal of Clinical Investigation·P Y Chen, P W Sanders
Aug 1, 1991·The Journal of Physiology·J A SmithM J Lewis
Sep 15, 1990·Lancet·T NakakiR Kato
Dec 1, 1989·Journal of Molecular and Cellular Cardiology·E D Frohlich
Oct 1, 1987·The Journal of Clinical Investigation·N H BishopricC P Ordahl
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S IzumoV Mahdavi
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·S D Gray
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Jun 1, 1994·Hypertension·N E RhalebO A Carretero

❮ Previous
Next ❯

Citations

Jul 1, 1998·Clinical Biochemistry·G EllisS K Makela
Apr 13, 2000·Pharmacology & Therapeutics·A M Shah, P A MacCarthy
Jul 20, 2001·International Journal of Cardiology·V S MujumdarS C Tyagi
Sep 21, 2000·Pathophysiology : the Official Journal of the International Society for Pathophysiology·S C Tyagi
Apr 16, 2003·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Koki NakamuraMohamed Amrani
Mar 23, 2004·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·David BellBarbara J McDermott
Nov 1, 2003·Antioxidants & Redox Signaling·Abdelkarim SabriPamela A Lucchesi
Jan 27, 1998·Current Opinion in Nephrology and Hypertension·A J Maxwell, J P Cooke
Mar 4, 2003·Journal of Cellular and Molecular Medicine·R L de Andrade ZorziC A Mandarim-de-Lacerda
Apr 18, 2008·Canadian Journal of Physiology and Pharmacology·Zoran MiloradovićSladan Milanović
Sep 1, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·David BellBarbara J McDermott
May 14, 2010·Journal of Inflammation·José L Miguel-CarrascoCarmen M Vázquez
Sep 13, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Masanori OzakiMitsuhiro Yokoyama
Feb 6, 2009·Journal of Cardiovascular Medicine·Simon W Rabkin, Shaun S Klassen
Mar 7, 2014·Canadian Journal of Physiology and Pharmacology·Karla Fabiana GoesslerMarcos Doederlein Polito
Jun 29, 2012·Bioscience, Biotechnology, and Biochemistry·Nahla ZghondaHitoshi Miyazaki
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Beate FiedlerKai C Wollert
Aug 5, 1999·The Journal of Physiology·T J Koh, J G Tidball
Oct 6, 2009·Journal of Molecular and Cellular Cardiology·J Craig HunterMorris Karmazyn
Mar 28, 2007·Heart Failure Clinics·Jonathan Passeri, Kenneth D Bloch
Oct 27, 2015·Journal of Pharmacological Sciences·Yingzi ZhaoSusan W S Leung
Jun 14, 2005·European Journal of Clinical Investigation·F SimkoI Bernatova
Mar 4, 2008·Basic & Clinical Pharmacology & Toxicology·Roselyn B Rose'MeyerLindsay Brown
Apr 7, 2006·The Journal of Veterinary Medical Science·Shunsuke ShimamuraYoshihisa Yamane
Apr 14, 2012·International Journal of Cardiology·Francesco PerticoneGiorgio Sesti
May 16, 1998·Biochemical and Biophysical Research Communications·T TsukadaJ Igari
May 6, 2016·Scientific Reports·Le Thi Thanh ThuyNorifumi Kawada
May 28, 2016·Chonnam Medical Journal·JongUn LeeSoo Wan Kim
Dec 6, 2008·American Journal of Hypertension·Wesley W BrooksOscar H L Bing
Mar 25, 2017·Expert Opinion on Therapeutic Targets·Lucas C PinheiroMichele M Castro
Sep 18, 2010·Journal of Hypertension·Gema Ruiz-Hurtado, Carmen Delgado
Jun 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Andrew FenningLindsay Brown
Jul 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·David BellBarbara J McDermott
Jul 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Matthew J HuntSuresh C Tyagi
Oct 28, 2019·The British Journal of Nutrition·Sarah Martin, Kaushik Desai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.